Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02876224
Title Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications

colorectal adenocarcinoma

Therapies

Atezolizumab + Bevacizumab + Cobimetinib

Age Groups: senior | adult
Covered Countries USA | ESP

Facility Status City State Zip Country Details
University Of Colorado Aurora Colorado 80045 United States Details
Memorial Sloan-Kettering Cancer Center New York New York 10065 United States Details
Sarah Cannon Research Inst. Nashville Tennessee 37203 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030-4009 United States Details
Hospital Universitario Vall d'Hebron Barcelona 08035 Spain Details
START Madrid. Centro Integral Oncologico Clara Campal; CIOCC Madrid 28050 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field